Cargando…

No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials

BACKGROUND AND OBJECTIVES: Statins showed mixed results in heart failure (HF) patients. The benefits in major HF outcomes, including all-cause mortality and sudden cardiac death (SCD), have always been discordant across systematic reviews and meta-analyses. We intended to systematically identify and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Gobari, Muaamar, Le, Hai-Ha, Fall, Mor, Gueyffier, François, Burnand, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293250/ https://www.ncbi.nlm.nih.gov/pubmed/28166237 http://dx.doi.org/10.1371/journal.pone.0171168

Ejemplares similares

Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews
por: Al-Gobari, Muaamar, et al.
Publicado: (2018)

Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials
por: Al-Gobari, Muaamar, et al.
Publicado: (2013)

Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Le, Hai-Ha, et al.
Publicado: (2016)

Are mind–body therapies effective for relieving cancer‐related pain in adults? A systematic review and meta‐analysis
por: Danon, Nadia, et al.
Publicado: (2021)

Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction
por: Cho, Jae Hyung
Publicado: (2022)

Are arrhythmias the drivers of sudden cardiac death in heart failure with preserved ejection fraction? A review
por: Yuyun, Matthew F., et al.
Publicado: (2022)

Arrhythmic Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction: Mechanisms, Genetics, and Future Directions
por: Safabakhsh, Sina, et al.
Publicado: (2022)

Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2020)

What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
por: Packer, Milton
Publicado: (2020)

Osteopontin and LDLR Are Upregulated in Hearts of Sudden Cardiac Death Victims With Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
por: Patel, Mausam, et al.
Publicado: (2020)

Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature
por: Techorueangwiwat, Chol, et al.
Publicado: (2021)

C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
por: Park, Jin Joo, et al.
Publicado: (2022)

Loss of skeletal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fraction
por: Matsumura, Koichiro, et al.
Publicado: (2020)

Machine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China
por: Meng, Fanqi, et al.
Publicado: (2019)

Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy
por: Pour-Ghaz, Issa, et al.
Publicado: (2022)

Prediction of sudden and non-sudden cardiac death in post-infarction patients with reduced left ventricular ejection fraction by periodic repolarization dynamics: MADIT-II substudy
por: Rizas, Konstantinos D., et al.
Publicado: (2017)

Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction
por: Brownell, Nicholas K., et al.
Publicado: (2022)

Organizational interventions and occupational burnout: a meta-analysis with focus on exhaustion
por: Bes, Isabelle, et al.
Publicado: (2023)

Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
por: Schrage, Benedikt, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
por: Choi, Ki Hong, et al.
Publicado: (2019)

Left Ventricular Geometry and Risk of Sudden Cardiac Arrest in Patients With Severely Reduced Ejection Fraction
por: Phan, Derek, et al.
Publicado: (2016)

Cause of Death Among Patients With Diabetes and Heart Failure With Reduced Ejection Fraction
por: Sharma, Abhinav, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Association between continuity of care (COC), healthcare use and costs: what can we learn from claims data? A rapid review
por: Nicolet, Anna, et al.
Publicado: (2022)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
por: Gosling, Rebecca C, et al.
Publicado: (2022)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction
por: Belkin, Mark N., et al.
Publicado: (2021)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction
por: Cuvelliez, Marie, et al.
Publicado: (2019)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Heart failure with reduced ejection fraction due topolycythemia vera
por: Zaman, Muhammad Omer, et al.
Publicado: (2021)

Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life
por: Vu, Katja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2nlb7mjjamioh293llihgofmje